Table 2 Prevalence of stages of chronic kidney disease according to the various estimating equations
Marker | Stage of | Description | eGFRa | Men | Women | Total |
|---|---|---|---|---|---|---|
CKD | N (%) | N (%) | N (%) | |||
MDRD | - | No kidney damage with normal or mildly decreased eGFR | ≥60 | 532 (63.6) | 368 (58.0) | 900 (61.2) |
1 | Kidney damage with normal eGFR | ≥90 | 3 (0.4) | 1 (0.2) | 4 (0.3) | |
2 | Kidney damage with mildly decreased eGFR | 60–89 | 46 (5.5) | 17 (2.7) | 63 (4.3) | |
3 | Moderately decreased eGFR | 30–59 | 245 (29.3) | 239 (37.6) | 484 (32.9) | |
4/5 | Severely decreased eGFR, kidney failure | <30 | 10 (1.2) | 10 (1.6) | 20 (1.4) | |
CKD-EPI | - | No kidney damage with normal or mildly decreased eGFR | ≥60 | 523 (62.6) | 396 (62.4) | 919 (62.5) |
1 | Kidney damage with normal eGFR | ≥90 | 2 (0.2) | 1 (0.2) | 3 (0.2) | |
2 | Kidney damage with mildly decreased eGFR | 60–89 | 46 (5.5) | 17 (2.7) | 63 (4.3) | |
3 | Moderately decreased eGFR | 30–59 | 253 (30.3) | 209 (32.9) | 462 (31.4) | |
4/5 | Severely decreased eGFR, kidney failure | <30 | 12 (1.4) | 12 (1.9) | 24 (1.6) | |
Cystatin-C based eGFR | - | No kidney damage with normal or mildly decreased eGFR | ≥60 | 645 (77.2) | 522 (82.2) | 1167 (79.3) |
1 | Kidney damage with normal eGFR | ≥90 | 18 (2.2) | 4 (0.6) | 22 (1.5) | |
2 | Kidney damage with mildly decreased eGFR | 60–89 | 53 (6.3) | 15 (2.4) | 68 (4.6) | |
3 | Moderately decreased eGFR | 30–59 | 113 (13.5) | 89 (14.0) | 202 (13.7) | |
4/5 | Severely decreased eGFR, kidney failure | <30 | 7 (0.8) | 5 (0.8) | 12 (0.8) |